A Comprehensive Scientific Claims on Ethnobotany, Phytochemical Pharmacological and Toxicology of Withania somnifera (L.) Dunal
An updated ethnobotany, phytochemical and pharmacological potential of Withania somnifera
Abstract
For more than 3,000 years, Withania somnifera, commonly known as Ashwagandha, has been utilised in traditional and Ayurvedic medicine. It belongs to the ginger family. Dry powder, crude extract, and refined metabolites of the plant have all demonstrated potential therapeutic advantages in animal trials because it is a medicinal plant. Withanolides are the primary metabolites of the plant, and they are responsible for the therapeutic effects of the herb. Despite the fact that other review papers on this plant have previously been published, this review article is being provided in order to gather all of based on the most recent data on its pharmacological and phytochemical effects, which have been investigated using a variety of approaches. According to research, Ashwagandha has anti-inflammatory, adaptogen, anti-parkinsonian, anti-oxidant, and memory-boosting properties, and anticancer effects in addition to other benefits. Other effects, such as immunomodulation, hypolipidemia, antimicrobial activity, Investigations have also been done on cardiovascular defence, sexual behaviour, tolerance, and reliance. These outcomes are extremely encouraging, and they recommend more research into this herb to confirm these results and find further potential medicinal characteristics. Clinical studies including the use of ashwagandha for a number of illnesses should be carried out as well. The new evidence on its pharmacological and phytochemical activities is described in the current publication. In order to give thorough information on the ethnobotany, traditional applications, phytochemistry, and pharmacological efficacy of the medicinal plant, W. somnifera, from reliable sources, the present review has primary objectives.
Keywords: Withania somnifera, Solanaceae, traditional claim, ethnobotany, phytochemistry, phytopharmacology
Keywords:
Withania somnifera, Solanaceae, traditional claim, ethnobotany, phytochemistry, phytopharmacologyDOI
https://doi.org/10.22270/jddt.v13i3.6003References
Qazi MA, Molvi KI. Herbal Medicine: A Comprehensive Review. International J Pharm Res. 2016; 8(2):1-5.
Israili AH. Humoral theory of Unanitibb. Indian J His of Sci. 1981; 16(1):95-99.
Dunn PM, Aristotle (384-322 BC): Philosopher and scientist of ancient Greece, Archives of Disease in Childhood & Neonatal Edition. 2006; 91(1):75-77. https://doi.org/10.1136/adc.2005.074534
Popa IC. The lists of plant synonyms in De Material medica of Dioscorides, Global J Sci Front Res. 2010; 10(3):46-49.
Sania Hamid, Carl Linnaeus (1707-1778) and plants in the traditions (Hadith) of Prophet Muhammad. Indian J Trad Know. 2007; 6(4): 692-694.
Verma S and Singh SP. Current and future status of herbal medicines. Veterinary World. 2008; 1(11):347-350. https://doi.org/10.5455/vetworld.2008.347-350
Jain R, Kachhwaha S, Kothari SL. Phytochemistry, pharmacology, and biotechnology of Withania somnifera and Withania coagulans: A review. J Med Plants Res. 2012; 6(41):5388-5399. https://doi.org/10.5897/JMPR12.704
Halder T and Ghosh B. Phytochemical and Pharmacological Activity of Withania somnifera (L.) Dunal. International Journal of Economic Plants. 2015; 2(4):192-96.
Negi MS, Sabharwal V, Wilson N, Lakshmikumaran MS. Comparative analysis of the efficiency of SAMPL and AFLP in assessing genetic relationships among Withania somnifera genotypes. Current Sci. 2006; 91: 464−471.
Pandey V, Ansari WA, Misra P, Atri N. Withania somnifera: Advances and Implementation of Molecular and Tissue Culture Techniques to Enhance Its Application. Front Plant Sci. 2017; 8:1390-11. https://doi.org/10.3389/fpls.2017.01390
Anonymous. Standardisation of Single Drugs of Unani Medicine. Part III, 1st ed. Central Council for Research in Unani Medicine (CCRUM), New Delhi. 2007; 9-14.
Chopra RN, Nayar SL and Chopra IC. Glossary of Indian Medicinal Plants. Council of Scientific & Industrial Research, New Delhi. 1980; 191, 258.
Kirtikar KR and Basu BD. Indian Medicinal Plants. 2nd ed. Vol. III, Lalit Mohan Basu, Allahabad, India. 1980; 1774-1777.
Nadkarni KM. Indian Materia Medica. 3rd ed. Vol. I, Popular Prakashan Pvt. Ltd., Bombay. 1982; 1292-1294.
Bano A, Sharma N, Dhaliwal HS, Sharma VA. Systematic and Comprehensive Review on Withania somnifera (L.) Dunal- An Indian Ginseng. British J Pharm Res. 2015; 7(2): 63-75. https://doi.org/10.9734/BJPR/2015/17102
Sharma V, Dhaliwal HS, Gupta RC, Singh B. Comparative evaluation of cytomorphological studies on 27 accessions of "Indian Ginseng" Withania somnifera (L.) Dunal from North India. Braz J Bot. 2014; 37(4):583-596. https://doi.org/10.1007/s40415-014-0094-x
Singh S, Kumar S. Withania somnifera: The Indian Ginseng, Ashwagandha. Central Institute of Medical and Aromatic Plants, Lucknow, India. 1998.
Verma SK, Shaban A, Purohit R, Chimata ML, Rai G, Verma OP. Immonomodulatory activity of Withania somnifera (L.). J Chem & Pharm Res. 2012; 4(1):559-561.
Atal CK, Gupta OP, Raghunathan K, Dhar KL. In: Pharmacognosy and Phytochemistry of Withania somnifera (linn.) Dunal (Ashwagandha). Central Council for Research in Indian Medicine and Homeopathy, New Delhi, India; 1975.
Paul S, Chakraborty S, Anand U, Dey S, Nandy S, Ghorai M, Saha SC, Patil MT, Kandimalla R, Proćków J, Dey A. Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects. Biomed Pharmacother. 2021; 143:121-75. https://doi.org/10.1016/j.biopha.2021.112175
Muhammad G, Hussain MA, Anwar F, Ashraf M, Gilani AH, Alhagi: A plant genus rich in bioactives for pharmaceuticals. Phytother Res. 2015; 29:1-13. https://doi.org/10.1002/ptr.5222
Rahmatullah M, Ferdausi D, Mollik MAH, Jahan R, Chowdhury MH, Haque WM. A survey of medicinal plants used by Kaverajes of Chalna area, Khulna District, Bangladesh. AfrJ Trad Comp Altr Med.2010; 7:91-97. https://doi.org/10.4314/ajtcam.v7i2.50859
Kumar A, Ali M, Rahman MS, Iqubal MA, Anand G, Kumar PN. Antidote effect of plants of Himalayan sub- origin against arsenic induced toxicity. J Bio Chem Res. 2015; 2: 99-109.
Glotter E. Withanolides and related ergostane-type steroids. Nat Prod Rep. 1991; 8:415-440. https://doi.org/10.1039/np9910800415
Javaid A, Shafique S, Shafique S. Management of Parthenium hysterophorus (Asteraceae) by Withania somnifera (Solanaceae). J Nat Prod Res. 2011; 25:407-416. https://doi.org/10.1080/14786419.2010.483230
Dutta R, Khalil R, Green R, Mohapatra SS, Mohapatra S. Withania Somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology. Int J Mol Sci. 2019; 20(21):5310. https://doi.org/10.3390/ijms20215310
Pant M, Ambwani T, Umapathi V. Antiviral activity of Ashwagandha extract on infectious bursal disease virus replication. Ind J Sci Technol. 2012; 5(5):2750-2751. https://doi.org/10.17485/ijst/2012/v5i5.20
Uddin Q, Samiulla L, Singh, VK and Jamil SS. Phytochemical and Pharmacological Profile of Withania somnifera Dunal: A Review. J Appl Pharm Sci. 2012; 02(01): 170-175.
Singh N, Bhalla M, De Jager P, Gilca M. An overview on Ashwagandha: a Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med. 2011; 8(S):208-213. https://doi.org/10.4314/ajtcam.v8i5S.9
Speers AB, Cabey KA, Soumyanath A, Wright KM. Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia. Curr Neuropharmacol. 2021; 19(9):1468-1495. https://doi.org/10.2174/1570159X19666210712151556
Ven Murthy M, Ranjekar PK, Ramassamy C, Deshpande M. Scientific basis for the use of Indian Ayurvedic medicinal plants in the treatment of neurodegenerative disorders: 1. Ashwagandha. Cent Nerv Syst Agents Med Chem. 2010; 10:238-246. https://doi.org/10.2174/1871524911006030238
Seenivasagam R, Sathiyamoorthy S, Hemavathi K. Therapeutic impacts of Indian and Korean ginseng on human beings-A review. Int J Immunol Stud. 2011; 1:297-317. https://doi.org/10.1504/IJIS.2011.041727
Grandhi A, Mujumdar AM, Patwardhan B. A comparative pharmacological investigation of Ashwagandha and Ginseng. J Ethnopharmacol. 1994; 44:131-135. https://doi.org/10.1016/0378-8741(94)01119-2
Saleem S, Muhammad G, Hussain MA, Altaf M, Bukhari SNA. Withania somnifera L.: Insights into the phytochemical profile, therapeutic potential, clinical trials, and future prospective. Iran J Basic Med Sci. 2020; 23:1501-1526.
Kalra R, Kaushik N. Withania somnifera (Linn.) Dunal: A review of chemical and pharmacological diversity. Phytochem Rev. 2017; 16:953-987. https://doi.org/10.1007/s11101-017-9504-6
Dar NJ, Hamid A, Ahmad M. Pharmacologic overview of Withania somnifera, the Indian Ginseng. Cell Mol Life Sci. 2015; 72:4445-4460. https://doi.org/10.1007/s00018-015-2012-1
Mirjalili MH, Moyano E, Bonfill M, Cusido RM, Palazon J. Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecules. 2009; 14:2373-2393. https://doi.org/10.3390/molecules14072373
Matsuda H, Murakami T, Kishi A, Yoshikawa M. Structures of withanolides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera DUNAL and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. Bioorg Med Chem. 2001; 9:1499-1507
https://doi.org/10.1016/S0968-0896(01)00024-4
Singh G, Sharma P, Dudhe R, Singh S. Biological activities of Withania somnifera. Ann Biol Res. 2010; 1:56-63
Majumdar DN. Withania somnifera Dunal. II Alkaloid constituents and their chemical characterisation. Indian J Pharmacol. 1955; 17:158-161.
Schwarting AE, Bobbit JM, Rother A. The alkaloids of W. somnifera. Llyoida. 1963; 26:258-273.
Jayaprakasam B, Strasburg GA, Nair MG. Potent lipid peroxidation inhibitors from Withania somnifera fruits. Tetrahedron. 2004; 60(13):3109-3121. https://doi.org/10.1016/j.tet.2004.01.016
Lavie D, Glotter E, Shvo Y. Constituents of Withania somnifera-III-the side chain of Withaferin A. J Org Chem. 1965; 30:1774-1778. https://doi.org/10.1021/jo01017a015
Lavie, D., Green, Field, S., Glotter, E. Constituents of Withania somnifera Dun. Part VI. The stereochemistry of withaferin A. J Chem Soc C. 1966; 19:1753-1756. https://doi.org/10.1039/j39660001753
Lavie D, Green Field S, Glotter E. Constituents of Withania somnifera Dun. Part VI. The stereochemistry of withaferin A. J Chem Soc C. 1966; 19:1753-1756. https://doi.org/10.1039/j39660001753
Lavie D, Kirson I, Abraham A, Jayaprakasam. Chemical approach to genetics. Isr J Chem. 1968; 14:60-68. https://doi.org/10.1002/ijch.197500045
Lavie D, Kirson I, Glotter E. Constituents of W. somnifera part X. The structure of withanolide D. Isr J Chem. 1968; 5(6):671-678. https://doi.org/10.1002/ijch.196800085
Lavie D, Kirson I, Glotter E. Crystal and molecular structure of withanolide E, A new natural steroidal lactone with a 17a-side-chain. J Chem Soc Chem Commun. 1972; 15:877-878. https://doi.org/10.1039/C39720000877
Abraham A, Kirson I, Lavie D. The withanolides of Withania somnifera chemotypes I and II. Phytochemistry. 1975; 14:189-194.
https://doi.org/10.1016/0031-9422(75)85035-7
Kirson I, Glotter E, Lavis D. Constituents of Withania somnifera Dunal XII. The withanolides of an Indian Chemotype. J Chem Soc (org). 1971; 52: 2032-2044. https://doi.org/10.1039/j39710002032
Velde VV, Lavie D. A D16-withanolide in Withania somnifera as a possible precursor for a-side-chains. Phytochemistry. 1982; 21(3):731-733. https://doi.org/10.1016/0031-9422(82)83176-2
Rahman AU, Abbas S, Shahwar DE, Jamal SA. Choudhary, M.I. New withanolides from Withania spp. J Nat Prod. 1993; 56(7):1000-1006 https://doi.org/10.1021/np50097a003
Rahman AU, Jamal SA, Choudhary MI, Asif E. Two withanolides from Withania somnifera. Phytochemistry.1991; 30(11):3824-3826. https://doi.org/10.1016/0031-9422(91)80125-K
Misra L, Lal P, Sangwan RS. Unusually sulfated and oxygenated steroids from Withania somnifera. Phytochemistry. 2005; 66(23):2702-2707. https://doi.org/10.1016/j.phytochem.2005.10.001
Ali M, Shuaib M and Ansari SH. Withanolides from the stem bark of Withania somnifera. Phytochemistry. 1997; 44(6):1163-68. https://doi.org/10.1016/S0031-9422(96)00656-5
Anjaneyulu ASR, Rao SD. New withanolides from the roots of Withania somnifera. Indian J Chem. 1997; 36(5):424- 433.
Jayaprakasam B, Strasburg GA, Nair MG. Potent lipid peroxidation inhibitors from Withania somnifera fruits. Tetrahedron. 2004; 60(13):3109-3121. https://doi.org/10.1016/j.tet.2004.01.016
Misra L, Mishra P, Pandey A. 1,4-Dioxane and ergosterol derivatives from Withania somnifera roots. J Asian Nat Prod Res. 2012; 14(1):39-45. https://doi.org/10.1080/10286020.2011.622719
Sharma S, Dahanukar S, Karandikar S. Effects of long term administration of the roots of Ashwagandha and Shatavari in rats. Indian Drugs. 1985; 22:133.
Prabu PC, Panchapakesan S, Raj CD. Acute and subacute oral toxicity assessment of the hydroalcoholic extract of Withania somnifera roots in Wistar rats. Phytother Res. 2013; 27:1169-1178. https://doi.org/10.1002/ptr.4854
Prabu PC, Panchapakesan S. Prenatal developmental toxicity evaluation of Withania somnifera root extract in Wistar rats. Drug Chem Toxicol. 2015; 38:50-56 https://doi.org/10.3109/01480545.2014.900073
Sharada A, Solomon FE, Devi PU. Toxicity of Withania somnifera root extract in rats and mice. Pharm Biol. 1993; 31:205-212. https://doi.org/10.3109/13880209309082943
Bisht P, Rawat V. Antibacterial activity of Withania somnifera against Gram-positive isolates from pus samples. Ayurveda. 2014; 35:330. https://doi.org/10.4103/0974-8520.153757
Alam N, Hossain M, Mottalib MA, Sulaiman SA, Gan SH. Methanolic extracts of Withania somnifera leaves, fruits and roots possess antioxidant properties and antibacterial activities. BMC Complement Altern Med. 2012; 12:175.
https://doi.org/10.1186/1472-6882-12-175
Mwitari PG, Ayeka PA, Ondicho J, Matu EN, Bii CC. Antimicrobial activity and probable mechanisms of action of medicinal plants of Kenya: Withania somnifera, Warbugia ugandensis, Prunus africana and Plectrunthus barbatus. PLoS One. 2013; 8(6):e65619. https://doi.org/10.1371/journal.pone.0065619
Girish KS, Machiah KD, Ushanandini S. Antimicrobial properties of a non-toxic glycoprotein (WSG) from Withania somnifera (Ashwagandha). J Basic Microbiol 2015; 46(5):365-374. https://doi.org/10.1002/jobm.200510108
Singariya P, Mourya KK, Kumar P. Comparative microcidal activity of Withania somnifera and Cenchrus setigerus against the pathogenic micro-organisms. Int J Pharm Pharmaceutical Sci. 2011; 3(5):511-515.
Singariya P, Kumar P, Mourya K. Antibacterial and antifungal potential of some polar solvent extracts of Ashwagandha (Solanaceae) against the nosocomial pathogens. Int J Green. 2012a; 6(1):17-22. https://doi.org/10.4103/0973-8258.97112
Singariya P, Kumar P, Mourya KK. Screening for antimicrobial potency of methanolic extract of Indian Ginseng. Int J Pharm Pharmaceutical Sci.2012b; 4(3):553-557. https://doi.org/10.4103/0976-9234.99665
Sumantran VN, Chandwaskar R, Joshi AK, Boddul S, Patwardhan B. The relationship between chondroprotective and antiinflammatory effects of Withania somnifera root and glucosamine sulphate on human osteoarthritic cartilage in vitro. Phytother Res. 2008; 22:1342-1348 https://doi.org/10.1002/ptr.2498
Sumantran VN, Kulkarni A, Boddul S, Chinchwade T, Koppikar SJ. Chondroprotective potential of root extracts of Withania somnifera in osteoarthritis. J Biosci. 2007: 32:299-307 https://doi.org/10.1007/s12038-007-0030-3
Singh D, Aggarwal A, Maurya R, Naik S. Withania somnifera inhibits NF-kappaB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells. Phytother Res. 2007; 21:905-913 https://doi.org/10.1002/ptr.2180
Rasool M, Varalakshmi P. Protective effect of Withania somnifera root powder in relation to lipid peroxidation, antioxidant status, glycoproteins and bone collagen on adjuvant induced arthritis in rats. Fundam Clin Pharmacol. 2007; 21:157-164. https://doi.org/10.1111/j.1472-8206.2006.00461.x
Gupta A, Singh S. Evaluation of anti-inflammatory effect of Withania somnifera root on collagen-induced arthritis in rats. Pharm Biol. 2014; 53: 308-320. https://doi.org/10.3109/13880209.2013.835325
Ganesan K, Sehgal PK, Mandal AB, Sayeed S. Protective effect of Withania somnifera and Cardiospermum halicacabum extracts against collagenolytic degradation of collagen. Appl Biochem Biotechnol. 2011; 165:1075-1091. https://doi.org/10.1007/s12010-011-9326-8
Dey D, Chaskar S, Athavale N, Chitre D. Inhibition of LPS-induced TNF-alpha and NO production in mouse macrophage and inflammatory response in rat animal models by a novel Ayurvedic formulation, BV-9238:2014. https://doi.org/10.1002/ptr.5151
Vaishnavi K, Saxena N, Shah N, Singh R, Manjunath K. Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences. PLoS One. 2012; 7:e44419 https://doi.org/10.1371/journal.pone.0044419
Mayola E, Gallerne C, Esposti DD, Martel C, Pervaiz S. Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down regulation of Bcl-2. Apoptosis. 2011; 16:1014-1027. https://doi.org/10.1007/s10495-011-0625-x
Yang ES, Choi MJ, Kim JH, Choi KS, Kwon TK. Withaferin A enhances radiation-induced apoptosis in Caki cells through induction of reactive oxygen species, Bcl-2 down regulation and Akt inhibition. Chem Biol Interact. 2011; 190:9-15 https://doi.org/10.1016/j.cbi.2011.01.015
Hahm ER, Singh SV. Autophagy fails to alter withaferin A-mediated lethality in human breast cancer cells. Curr Cancer Drug Targets. 2013b; 13:640-650 https://doi.org/10.2174/15680096113139990039
Hahm ER, Lee J, Kim SH, Sehrawat A, Arlotti JA. Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model. J Natl Cancer Inst. 2013a; 105:1111-1122. https://doi.org/10.1093/jnci/djt153
Hahm ER, Lee J, Singh SV. Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells. Mol Carcinog. 2015; 53:907-916 https://doi.org/10.1002/mc.22050
Hahm ER, Moura MB, Kelley EE, Van Houten B, Shiva S. Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species. PLoS One. 2014; 6:e23354. https://doi.org/10.1371/journal.pone.0023354
Kim SH, Singh SV. Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cells. Cancer Prev Res (Phila). 2014; 7:738-747. https://doi.org/10.1158/1940-6207.CAPR-13-0445
Lee J, Sehrawat A, Singh SV. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells. Breast Cancer Res Treat. 2012; 136:45-56. https://doi.org/10.1007/s10549-012-2239-6
Um HJ, Min KJ, Kim DE, Kwon TK. Withaferin A inhibits JAK/STAT3 signaling and induces apoptosis of human renal carcinoma Caki cells. Biochem Biophys Res Commun. 2012; 427:24-29. https://doi.org/10.1016/j.bbrc.2012.08.133
Rastogi RP and Mehrotra BN. Compendium of Indian Medicinal Plants. 2nd Reprint, Central Drug Research Institute, Lucknow and National Institute of Science Communication, Council of Scientific and Industrial Research, New Delhi (1998), Vol. 1: 434-436; Vol. 2: 708-710; Vol. 3: 682-684; Vol. 4: 765-766; Vol. 5: 889-891; Vol. 6: 148.
Anonymous. The Wealth of India. Vol. X (Sp-W), Publications and Information Directorate, Council of Scientific and Industrial Research (CSIR), New Delhi. 1982; 580-585.
Khare CP. Indian Medicinal Plants-An Illustrated Dictionary. First Indian Reprint, Springer (India) Pvt. Ltd., New Delhi. 2007; 717-718. https://doi.org/10.1007/978-0-387-70638-2
Gauttam, V.K., Kalia, A.N., Development of polyherbal antidiabetic formulation encapsulated in the phospholipids vesicle system. J Adv Pharm Technol Res 4, 2013; 108-117. https://doi.org/10.4103/2231-4040.111527
Devi, P.U., Akagi K., Ostapenko, V., Tanaka, Y., Sugahara T. Withaferin A: A new radiosensitizer from Indian medicinal plant Withania somnifera. Intl J Radiation Biol. 1996; 69(2):193-197. https://doi.org/10.1080/095530096146020
Sharada, A.C., Solomon, F.E., Devi, P.U., Udupa, N., Srinivasan K.K. Antitumour and radio sensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma in vivo. Acta. Oncology. 1996; 35(1):95-100. https://doi.org/10.3109/02841869609098486
Mohanty, I.R., Arya, D.S., Gupta, S.K. Withania somnifera provides cardioprotection and attenuates ischemia-reperfusion induced apoptosis. Clin Nutr. 2008; 27:635-642 https://doi.org/10.1016/j.clnu.2008.05.006
Mohan, R., Hammers, H.J., Bargagna-Mohan, P., Zhan, X.H., Herbstritt, C.J. et al., Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis. 2004; 7:115-122. https://doi.org/10.1007/s10456-004-1026-3
Thirunavukkarasu, M., Penumathsa, S., Juhasz, B., Zhan, L., Bagchi, M. et al., Enhanced cardiovascular function and energy level by a novel chromium (III) supplement. Bio Factors 2006; 27:53-67. https://doi.org/10.1002/biof.5520270106
Reuland, D.J., Khademi, S., Castle, C.J., Irwin, D.C., McCord, J.M. et al., Upregulation of phase II enzymes through phytochemical activation of Nrf2 protects cardiomyocytes against oxidant stress. Free Radic Biol Med. 2013; 56:102-111. https://doi.org/10.1016/j.freeradbiomed.2012.11.016
Aphale, A.A., Chhibba, A.D., Kumbhakarna, N.R., Mateenuddin, M., Dahat, S.H. Subacute toxicity study of the combination of ginseng (Panax ginseng) and ashwagandha (Withania somnifera) in rats: a safety assessment. Indian J Physiol Pharmacol. 1998; 42:299-302
Ashour, O.M., Abdel-Naim, A.B, Abdallah, H.M., Nagy, A.A., Mohamadin, A.M et al., Evaluation of the potential cardioprotective activity of some Saudi plants against doxorubicin toxicity. Z Naturforsch C. 2012; 67:297-307 https://doi.org/10.1515/znc-2012-5-609
Gupta, S.K., Mohanty, I., Talwar, K.K., Dinda, A., Joshi, S. et al., Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment. Mol Cell Biochem. 2004; 260:39-47. https://doi.org/10.1023/B:MCBI.0000026051.16803.03
Hamza, A., Amin, A., Daoud, S. The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in rats. Cell Biol Toxicol. 2008; 24:63-73. https://doi.org/10.1007/s10565-007-9016-z
Bhattacharya, S.K., Satyan, K.S., Chakrabarti, A. Effect of Trasina, an Ayurvedic herbal formulation, on pancreatic islet superoxide dismutase activity in hyperglycaemic rats. Indian J Exp Biol. 1997; 35:297-299.
Bhattacharya SK, Satyan KS, Chakrabarti A. Effect of Trasina, an Ayurvedic herbal formulation, on pancreatic islet superoxide dismutase activity in hyperglycaemic rats. Indian J Exp Biol. 1997; 35:297-299.
Mutalik S, Chetana M, Sulochana B, Devi PU, Udupa N. Effect of Dianex, A herbal formulation on experimentally induced diabetes mellitus. Phytother Res. 2005; 19:409-415. https://doi.org/10.1002/ptr.1570
Andallu B, Radhika B. Hypoglycemic, diuretic and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) root. Indian J Exp Biol. 2000; 38:607-609.
Anwer T, Sharma M, Pillai KK, Iqbal, M. Effect of Withania somnifera on insulin sensitivity in non-insulin-dependent diabetes mellitus rats. Basic Clin Pharmacol Toxicol. 2008; 102:498-503. https://doi.org/10.1111/j.1742-7843.2008.00223.x
Dar NJ, Muzamil Ahmad. Neurodegenerative diseases and Withania somnifera (L.): An update. J Ethnopharmacol. 2020; 28:112769. https://doi.org/10.1016/j.jep.2020.112769
Udayakumar R, Kasthurirengan S, Mariashibu TS, Rajesh M, Anbazhagan VR, Kim SC, Ganapathi A, Choi CW. Hypoglycaemic and hypolipidaemic effects of Withania somnifera root and leaf extracts on alloxan-induced diabetic rats. Int J Mol Sci. 2009; 10(5):2367-2382. https://doi.org/10.3390/ijms10052367
Babu PV, Gokulakrishnan A, Dhandayuthabani R, Ameethkhan D, Kumar CV. Protective effect of Withania somnifera (Solanaceae) on collagen glycation and cross-linking Comp Biochem Physiol B Biochem Mol Biol. 2007; 147:308-313. https://doi.org/10.1016/j.cbpb.2007.01.011
Bhattacharya A, Ramanathan M, Ghosal S. Effect of Withania somnifera glycowithanolides on iron-induced hepatotoxicity in rats. Phytother Res. 2000; 14(7):568-570 https://doi.org/10.1002/1099-1573(200011)14:7<568::AID-PTR663>3.0.CO;2-Q
Harikrishnan B, Subramanian P, Subash S. Effect of Withania somnifera root powder on the levels of circulatory lipid peroxidation and liver marker enzymes in chronic hyperammonemia. E J Chem.2008; 5(4):872-877 https://doi.org/10.1155/2008/589394
SoRelle JA, Itoh T, Peng H, Kanak MA, Sugimoto K. Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation. Diabetologia. 2013; 56:814-824. https://doi.org/10.1007/s00125-012-2813-9
Sabina EP, Rasool M, Vedi M. Hepatoprotective and antioxidant potential of Withania somnifera against paracetamol-induced liver damage in rats. Int J Pharm Pharm Sci. 2013; 5(2):648-651.
Bhattacharya SK, Satyan KS. Experimental methods for evaluation of psychotropic agents in rodents: I-Anti-anxiety agents. Indian J Exp Biol. 1997; 35:565-575.
Rahman AU, Shabbir M, Yousaf M, Qureshi S, Shahwar DE, Naz A, Choudhary MI. Three withanolides from Withania coagulans. Phytochem. 1999; 52(7):1361-1364. https://doi.org/10.1016/S0031-9422(99)00416-1
Ziauddin M, Phansalkar N, Patki P. Studies on the immunomodulatory effects of Ashwagandha. J Ethnopharmacol. 1996; 50(2):69-76. https://doi.org/10.1016/0378-8741(95)01318-0
Davis L, Kuttan G. Immunomodulatory activity of Withania somnifera. J Ethnopharmacol. 2000; 71(1-2):193-200. https://doi.org/10.1016/S0378-8741(99)00206-8
Kuboyama T, Tohda C, Komatsu K. Effects of Ashwagandha (roots of Withania somnifera) on neurodegenerative diseases. Biol Pharm Bull. 2014; 37:892-897. https://doi.org/10.1248/bpb.b14-00022
Singh RH, Narsimhamurthy K, Singh G. Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontol. 2008; 9: 369-374. https://doi.org/10.1007/s10522-008-9185-z
Wollen KA. Alzheimer's disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. Altern Med Rev. 2010; 15(3):223-244.
Kumar A, Ali M, Rahman MS, Iqubal MA, Anand G, Kumar PN. Antidote effect of plants of Himalayan sub- origin against arsenic induced toxicity. J Bio Chem Res. 2015; 2:99-109.
Kumar P, Singh R, Nazmi A, Lakhanpal D, Kataria H. Glioprotective effects of Ashwagandha leaf extract against lead induced toxicity. Biomed Res Int. 2014; 1820-29. https://doi.org/10.1155/2014/182029
Parihar MS, Hemnani T. Alzheimer's disease pathogenesis and therapeutic interventions. J Clin Neurosci. 2004; 11:456-467. https://doi.org/10.1016/j.jocn.2003.12.007
Ahmed ME, Javed H, Khan MM, Vaibhav K, Ahmad A. Attenuation of oxidative damage-associated cognitive decline by Withania somnifera in rat model of streptozotocin induced cognitive impairment. Protoplasma. 2013; 250:1067-1078. https://doi.org/10.1007/s00709-013-0482-2
Manjunath MJ, Muralidhara. Effect of Withania somnifera supplementation on rotenone-induced oxidative damage in cerebellum and striatum of the male mice brain. Cent Nerv Syst Agents Med Chem. 2013; 13: 43-56. https://doi.org/10.2174/1871524911313010007
Pingali U, Pilli R, Fatima N. Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participants. Pharmacog Res. 2014; 6:12-18. https://doi.org/10.4103/0974-8490.122912
Prakash J, Chouhan S, Yadav SK, Westfall S, Rai SN. Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons. Neurochem Res. 2014; 39: 2527-2536. https://doi.org/10.1007/s11064-014-1443-7
Sehgal, N., Gupta, A., Valli, R.K., Joshi, S.D., Mills, J.T. Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci USA. 2012; 109:3510-3515. https://doi.org/10.1073/pnas.1112209109
Grover A, Shandilya A, Agrawal V, Bisaria VS, Sundar, D. Computational evidence to inhibition of human acetyl cholinesterase by withanolide a for Alzheimer treatment. J Biomol Struct Dyn. 2012; 29:651-662. https://doi.org/10.1080/07391102.2012.10507408
Yadav CS, Kumar V, Suke SG, Ahmed RS, Mediratta PK. Propoxur-induced acetylcholine esterase inhibition and impairment of cognitive function: attenuation by Withania somnifera. Indian J Biochem Biophys. 2010; 47:117-120.
Kurapati KR, Samikkannu T, Atluri VS, Kaftanovskaya E, Yndart A. Beta-Amyloid1-42, HIV-1Ba-L (clade B) infection and drugs of abuse induced degeneration in human neuronal cells and protective effects of Ashwagandha (Withania somnifera) and its constituent Withanolide A. PLoS One. 2014; 9: 818. https://doi.org/10.1371/journal.pone.0112818
Kurapati KR, Atluri VS, Samikkannu T, Nair MP. Ashwagandha (Withania somnifera) reverses beta-amyloid1-42 induced toxicity in human neuronal cells: implications in HIVassociated neurocognitive disorders (HAND). PLoS One. 2013; 8:e7762
https://doi.org/10.1371/journal.pone.0077624
Kumar S, Seal CJ, Howes MJ, Kite GC, Okello EJ. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and beta-amyloid (1-42)-induced cytotoxicity in differentiated PC12 cells. Phytother Res. 2010; 24:1567-1574. https://doi.org/10.1002/ptr.3261
Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012; 34:255-262. https://doi.org/10.4103/0253-7176.106022
Ramanathan M, Balaji B, Justin A. Behavioural and neurochemical evaluation of Perment an herbal formulation in chronic unpredictable mild stress induced depressive model. Indian J Exp Biol. 2011; 49:269-275.
Kaurav BPS, Wanjari MM, Chandekar A. Influence of Withania somnifera on obsessive compulsive disorder in mice. Asian Pac J Trop Med. 2012; 5(5):380-384 https://doi.org/10.1016/S1995-7645(12)60063-7
Published



How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).